Screening patients with certain cancers for NCI Surgery Branch treatment studies
Screens adults with cancer to see if they qualify for cell-based treatment studies.
Plain-language title generated from the registry record
Registry title: Evaluation for NCI Surgery Branch Clinical Research Protocols
Key facts
- Where
- Bethesda, United StatesSee the site
Where in United States
- National Institutes of Health Clinical CenterBethesda, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- National Cancer Institute (NCI)
- Trial code
- NCT00001823
- Record updated
- 9 November 2026
- Original description
Background:Read full original descriptionShow less
Evaluation for NCI Surgery Branch Clinical Research Protocols
Background:
The National Cancer Institute Surgery Branch (NCI-SB) has developed experimental therapies that involve taking white blood cells from patients' tumor or from their blood, growing them in the laboratory in large numbers, and then giving the cells back to the patient.
Objective:
This study will allow patients to under screening and evaluation for participation in NC-SB Protocols.
Eligibility:
Patients 18 years or older must meet the minimum eligibility criteria for an NCI-SB treatment protocol.
Design
Patients will undergo testing and evaluations as required by the appropriate NCI-SB treatment protocol.
...
Exclusion: Women of child-bearing potential who are pregnant or plan to become pregnant because of the potentially dangerous effects of some of the screening procedures (e.g., nuclear medicine or other imaging scans) on the fetus.
INCLUSION CRITERIA:; Age >= 18 years; Patient suspected of having, or with biopsy proven, malignant disease; Patient is able to understand and willing to sign a written informed consent document; Patient is being evaluated for treatment on an NCI-SB protocols.